ProPublica reporters are looking into the booming business around peripheral artery disease, a condition that afflicts 6.5 million Americans over age 40. It’s caused when fatty plaque builds up in a ...

WASHINGTON, DC – OCTOBER 29, 2024 – Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with ...

Please provide your email address to receive an email when new articles are posted on . In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel ...

WASHINGTON, DC — Atherectomy has no advantage over conventional balloon angioplasty for the treatment of severe calcified lesions, according to unexpected results from the largest trial of the ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Percutaneous coronary intervention (PCI) is a standard treatment for significant coronary artery disease. Cardiologists use a catheter to place a stent that opens up the blockage and restores blood ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

CHATTANOOGA, TN – March is known for many things and among the madness that it always brings, it’s known for National Kidney Awareness Month. Somewhere around 30 million Americans have various kidney ...

The recent New York Times article highlighting inappropriate treatment patterns among patients with peripheral artery disease (PAD) has made a serious but much needed impact on patients and physicians ...

Medtronic and the FDA are expanding the reach of a Class I recall handed down in January for the medtech giant’s catheter designed to clear out clogged arteries. The previous recall covered more than ...